Therapeutic Cancer Vaccination with Immunopeptidomics-Discovered Antigens Confers Protective Antitumor Efficacy

SIMPLE SUMMARY: Immunotherapy has revolutionized cancer treatment, yet many tumors remain resistant to current immuno-oncology therapies. Here we explore a novel, customized oncolytic adenovirus vaccine platform as immunotherapy in a resistant tumor model. We present a workflow for customizing the o...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancers (Basel)
Main Authors: Peltonen, Karita, Feola, Sara, Umer, Husen M., Chiaro, Jacopo, Mermelekas, Georgios, Ylösmäki, Erkko, Pesonen, Sari, Branca, Rui M. M., Lehtiö, Janne, Cerullo, Vincenzo
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2021
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8306067/
https://ncbi.nlm.nih.gov/pubmed/34298622
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13143408
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki